Restylane Silk Microinjections to Cheeks
A Single Center, Prospective, Open-label, Clinical Trial Using Micro-injections of Transparent Hyaluronic Acid Gel (Restylane® Silk) for Rejuvenation of the Aging Cheek
Sponsor: Goldman, Butterwick, Fitzpatrick and Groff
This NA trial investigates Wrinkle and is currently ongoing. Goldman, Butterwick, Fitzpatrick and Groff leads this study, which shows 8 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Oct 2021 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
-
Feb 2020 — Jan 2021 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Jun 2019 — Feb 2020 [monthly]
Recruiting NA
-
Mar 2019 — Jun 2019 [monthly]
Recruiting NA
-
Dec 2018 — Mar 2019 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Goldman, Butterwick, Fitzpatrick and Groff
For direct contact, visit the study record on ClinicalTrials.gov .